916 related articles for article (PubMed ID: 30808384)
1. FGF23 and its role in X-linked hypophosphatemia-related morbidity.
Beck-Nielsen SS; Mughal Z; Haffner D; Nilsson O; Levtchenko E; Ariceta G; de Lucas Collantes C; Schnabel D; Jandhyala R; Mäkitie O
Orphanet J Rare Dis; 2019 Feb; 14(1):58. PubMed ID: 30808384
[TBL] [Abstract][Full Text] [Related]
2. Molecular Diagnoses of X-Linked and Other Genetic Hypophosphatemias: Results From a Sponsored Genetic Testing Program.
Rush ET; Johnson B; Aradhya S; Beltran D; Bristow SL; Eisenbeis S; Guerra NE; Krolczyk S; Miller N; Morales A; Ramesan P; Sarafrazi S; Truty R; Dahir K
J Bone Miner Res; 2022 Feb; 37(2):202-214. PubMed ID: 34633109
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
[TBL] [Abstract][Full Text] [Related]
4. A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells.
Ichikawa S; Austin AM; Gray AK; Econs MJ
J Bone Miner Res; 2012 Feb; 27(2):453-60. PubMed ID: 22006791
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of PHEX Mutations and FGF23 Profiles in a Taiwanese Cohort With X-Linked Hypophosphatemia Including 102 Patients.
Su PH; Yu JS; Wu YZ; Tsai YS; Lo FS; Lin JL; Chao MC; Hsu CC; Ke YY; Chiu PC; Chen JC; Huang YH; Lin SP; Chou YY; Ting WH; Wang SY; Chiu CF; Huang YC; Hsiao HP; Lin CH; Wang CH; Bau DT; Lin CY
In Vivo; 2024; 38(1):341-350. PubMed ID: 38148081
[TBL] [Abstract][Full Text] [Related]
6. Complex intrinsic abnormalities in osteoblast lineage cells of X-linked hypophosphatemia: Analysis of human iPS cell models generated by CRISPR/Cas9-mediated gene ablation.
Nakanishi T; Yamazaki M; Tachikawa K; Ueta A; Kawai M; Ozono K; Michigami T
Bone; 2024 Apr; 181():117044. PubMed ID: 38331306
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype analysis, and assessment of the importance of the zinc-binding site in PHEX in Japanese patients with X-linked hypophosphatemic rickets using 3D structure modeling.
Ishihara Y; Ohata Y; Takeyari S; Kitaoka T; Fujiwara M; Nakano Y; Yamamoto K; Yamada C; Yamamoto K; Michigami T; Mabe H; Yamaguchi T; Matsui K; Tamada I; Namba N; Yamamoto A; Etoh J; Kawaguchi A; Kosugi R; Ozono K; Kubota T
Bone; 2021 Dec; 153():116135. PubMed ID: 34333162
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-mediated mutation of PHEX in rabbit recapitulates human X-linked hypophosphatemia (XLH).
Sui T; Yuan L; Liu H; Chen M; Deng J; Wang Y; Li Z; Lai L
Hum Mol Genet; 2016 Jul; 25(13):2661-2671. PubMed ID: 27126636
[TBL] [Abstract][Full Text] [Related]
9. X-Linked Hypophosphatemia: Uniquely Mild Disease Associated With PHEX 3'-UTR Mutation c.*231A>G (A Retrospective Case-Control Study).
Smith PS; Gottesman GS; Zhang F; Cook F; Ramirez B; Wenkert D; Wollberg V; Huskey M; Mumm S; Whyte MP
J Bone Miner Res; 2020 May; 35(5):920-931. PubMed ID: 31910300
[TBL] [Abstract][Full Text] [Related]
10. High iFGF23 level despite hypophosphatemia is one of the clinical indicators to make diagnosis of XLH.
Igaki JM; Yamada M; Yamazaki Y; Koto S; Izawa M; Ariyasu D; Suzuki E; Hasegawa H; Hasegawa Y
Endocr J; 2011; 58(8):647-55. PubMed ID: 21597229
[TBL] [Abstract][Full Text] [Related]
11. Impact of X-Linked Hypophosphatemia on Muscle Symptoms.
Romagnoli C; Iantomasi T; Brandi ML
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553684
[TBL] [Abstract][Full Text] [Related]
12. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.
Kinoshita Y; Fukumoto S
Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780
[TBL] [Abstract][Full Text] [Related]
13. X-linked hypophosphatemia: Management and treatment prospects.
Lambert AS; Zhukouskaya V; Rothenbuhler A; Linglart A
Joint Bone Spine; 2019 Nov; 86(6):731-738. PubMed ID: 30711691
[TBL] [Abstract][Full Text] [Related]
14. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
Quarles LD
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
[TBL] [Abstract][Full Text] [Related]
15. Novel PHEX gene locus-specific database: Comprehensive characterization of vast number of variants associated with X-linked hypophosphatemia (XLH).
Sarafrazi S; Daugherty SC; Miller N; Boada P; Carpenter TO; Chunn L; Dill K; Econs MJ; Eisenbeis S; Imel EA; Johnson B; Kiel MJ; Krolczyk S; Ramesan P; Truty R; Sabbagh Y
Hum Mutat; 2022 Feb; 43(2):143-157. PubMed ID: 34806794
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of X-linked hypophosphatemia in children and adolescent in the Gulf Cooperation Council countries.
Al Juraibah F; Al Amiri E; Al Dubayee M; Al Jubeh J; Al Kandari H; Al Sagheir A; Al Shaikh A; Beshyah SA; Deeb A; Habeb A; Mustafa M; Zidan H; Mughal MZ
Arch Osteoporos; 2021 Mar; 16(1):52. PubMed ID: 33660084
[TBL] [Abstract][Full Text] [Related]
17. Effects of Burosumab Treatment on Two Siblings with X-Linked Hypophosphatemia. Case Report and Literature Review.
Jurca CM; Iuhas O; Kozma K; Petchesi CD; Zaha DC; Bembea M; Jurca S; Paul C; Jurca AD
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011303
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic role of Fgf23 in Hyp mice.
Liu S; Zhou J; Tang W; Jiang X; Rowe DW; Quarles LD
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E38-49. PubMed ID: 16449303
[TBL] [Abstract][Full Text] [Related]
19. Mineralized tissues in hypophosphatemic rickets.
Robinson ME; AlQuorain H; Murshed M; Rauch F
Pediatr Nephrol; 2020 Oct; 35(10):1843-1854. PubMed ID: 31392510
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
